• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】35308

【品名】(1S)-2-[(8S,13S,14S,17S)-13,17-dimethyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-methyl-2-oxoethyl acetate

【CA登记号】

【 分 子 式 】C24H32O4

【 分 子 量 】384.51568

【元素组成】C 74.97% H 8.39% O 16.64%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(X)

Trimegestone has been obtained by several related ways: 1) The reaction of 3,3-(ethylenedioxy)estra-5(10),9(11)-dien-17-one (I) with KCN and acetic acid in methanol, followed by silylation with TMSCl, gives the silylated cyanohydrin (II), which is treated with ethylmagnesium bromide in THF to yield the 17beta-propionyl derivative (III). Acetylation of the 17alpha-hydroxy group of (III) with Ac2O affords acetate (IV), which is methylated with MeI and lithium amide in liquid ammonia, giving the 17alpha-methyl derivative (V). The oxidation of (V) with t-BuOK and oxygen in DMF yields the 17beta-(2-oxopropionyl) derivative (VI), which is isomerized with acetic acid/ hydrochloric acid or acetic acid/perchloric acid, affording 17alpha-methyl-17beta-(2-oxopropionyl)estra-4,9-dien-3-one (VII). Finally, this compound is regio- and enantioselectively reduced with Saccharomyces cerevisiae in a sodium acetate buffer. 2) The reaction of the 17alpha-methyl derivative (V) with t-BuOK and iodine in THF gives the 17beta-(2-iodopropionyl) compound (VIII), which by reaction with KOAc in DMF, followed by treatment with acetic acid/perchloric acid as before, is converted into the 17beta-(2-acetoxypropionyl) derivative (IX). Finally, the acetoxy group of (IX) is hydrolyzed with KOH in methanol and the mixture of (R)- and (S)-diastereomers is separated by HPLC over silicagel. 3) The 17beta-(2-acetoxypropionyl) derivative (IX) can also be obtained directly by carefully controlled direct oxidation of the 17alpha-methyl-17beta-propionyl intermediate (V) with dry air in DMF in the presence of t-BuOK and triethyl phosphite. 4) The diastereoselective hydrolysis of the 17beta-(2-acetoxypropionyl) intermediate (IX) with lipase PS Amano in n-butanol/pH = 5 buffer gives a mixture of unreacted 17beta-[2(S)-acetoxypropinyl] derivative (X) and 17beta-[2(R)-hydroxypropionyl] derivative (XI). This mixture, without separation, is treated with methanesulfonyl chloride and Et3N in dichloromethane to yield a new mixture of the unreacted 17beta-[2(S)-acetoxypropionyl] derivative (X) and 17beta-[2(R)-(methanesulfonyloxy)propionyl] derivative (XII). The reaction of this mixture with potassium acetate in hot bis(2-methoxyethyl)ether affords pure 17beta-[2(S)-acetoxypropionyl] derivative (X), since the acetolysis of the sulfonate (XII) takes place with inversion of the configuration. Finally, this compound is hydrolyzed with KOH in methanol.

1 Leeson, P.A.; Casataner, J.; Sorbera, L.A.; Trimegestone. Drugs Fut 2000, 25, 5, 465.
2 Prat, D.; Richard, C.; Crocq, V.; Vivat, M.; Masson, C.; Lenay, J.; Winter, J.; Buendia, J.; Lemaitre, G.; Synthesis of trimegestone: The first industrial application of Bakers' yeast mediated reduction of a ketone. Org Process Res Dev 1997, 1, 1, 2-13.
3 Crocq, V.; Prat, D.; Vivat, M.; Buendia, J.; Masson, C. (Aventis Pharma SA); A new process for the preparation of 20-keto-21alpha-hydroxy steroid cpds. and intermediates thereof. EP 0574317; FR 2692267; JP 1994065283; US 5399685 .
4 Mackiewicz, P.; Godard, J.-Y.; Buendia, J.; Richard, C. (Aventis Pharma SA); New method of production of 20-keto 21(S)-hydroxy steroid cpds. and intermediates thereof. EP 0581649; FR 2694007; JP 1994181796; US 5384419 .
5 Coussediere, D. (Aventis Pharma SA); Novel 3,20-dioxo-4,9-diene-21-hydroxy steroid cpds., process for their preparation, their use in medicines and pharmaceutical compsns. containing them. EP 0007823; EP 0046001; FR 2430953; JP 1980015475; JP 1988033395; US 4273771 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30502 3,3-Ethylenedioxyestra-5(10),9(11)-dien-17-one 5571-36-8 C20H26O3 详情 详情
(II) 35301   C24H35NO3Si 详情 详情
(III) 35302   C23H32O4 详情 详情
(IV) 35303   C25H34O5 详情 详情
(V) 35304   C24H34O3 详情 详情
(VI) 35305   C24H32O4 详情 详情
(VII) 35306 1-[(8S,13S,14S,17S)-13,17-dimethyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1,2-propanedione C22H28O3 详情 详情
(VIII) 35309   C24H33IO3 详情 详情
(IX) 35307 2-[(8S,13S,14S,17S)-13,17-dimethyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-methyl-2-oxoethyl acetate C24H32O4 详情 详情
(X) 35308 (1S)-2-[(8S,13S,14S,17S)-13,17-dimethyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-methyl-2-oxoethyl acetate C24H32O4 详情 详情
(XI) 35310 (8S,13S,14S,17S)-17-[(2R)-2-hydroxypropanoyl]-13,17-dimethyl-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one C22H30O3 详情 详情
(XII) 35311 (1R)-2-[(8S,13S,14S,17S)-13,17-dimethyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-methyl-2-oxoethyl methanesulfonate C23H32O5S 详情 详情
Extended Information